Drug Shortage Report for OZEMPIC
| Report ID | 208495 |
| Drug Identification Number | 02471477 |
| Brand name | OZEMPIC |
| Common or Proper name | OZEMPIC 0.25MG/0.5MG |
| Company Name | NOVO NORDISK CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SEMAGLUTIDE |
| Strength(s) | 1.34MG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
| Packaging size | 1 |
| ATC code | A10BJ |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-11-15 |
| Actual start date | |
| Estimated end date | 2024-02-15 |
| Actual end date | 2024-02-16 |
| Shortage status | Resolved |
| Updated date | 2024-04-05 |
| Company comments | Health Canada expedited the approval of a new 3 mL Ozempic® low dose (0.25mg/0.5mg) pen to stabilize Ozempic® low dose (0.25mg/0.5mg) supply. The shortage of the Ozempic® (0.25mg/0.5mg) pen listed on the Drug Shortages webpage applies only to the previous 1.5mL pen and will be maintained until the transition to the new 3mL pen is complete. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
| Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v15 | 2024-04-05 | English | Compare |
| v14 | 2024-02-17 | English | Compare |
| v13 | 2024-02-16 | French | Compare |
| v12 | 2024-02-16 | English | Compare |
| v11 | 2024-02-08 | French | Compare |
| v10 | 2024-02-08 | English | Compare |
| v9 | 2024-01-17 | French | Compare |
| v8 | 2024-01-17 | English | Compare |
| v7 | 2024-01-17 | French | Compare |
| v6 | 2024-01-17 | English | Compare |
| v5 | 2023-12-12 | English | Compare |
| v4 | 2023-11-16 | English | Compare |
| v3 | 2023-10-30 | French | Compare |
| v2 | 2023-10-30 | English | Compare |
| v1 | 2023-10-30 | English | Compare |
Showing 1 to 15 of 15